Clinical trials
Completed Hypertension trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
128 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 7 |
| 2005 | 5 |
| 2006 | 11 |
| 2007 | 14 |
| 2008 | 20 |
| 2009 | 8 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 6 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 128 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 14 |
| Novartis Pharmaceuticals | 12 |
| AstraZeneca | 10 |
| Assistance Publique - Hôpitaux de Paris | 8 |
| Central Hospital, Nancy, France | 6 |
| Bial - Portela C S.A. | 4 |
| Bristol-Myers Squibb | 4 |
| Institut National de la Santé Et de la Recherche Médicale, France | 4 |
| Novartis | 4 |
| University Hospital, Grenoble | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 128 |
| Cardiovascular Diseases | 7 |
| Diabetes Mellitus, Type 2 | 7 |
| Diabetes Mellitus | 6 |
| Essential Hypertension | 6 |
| Heart Failure | 6 |
| Obesity | 5 |
| Kidney Diseases | 4 |
| Metabolic Syndrome | 4 |
| Sleep Apnea, Obstructive | 4 |
Trials
Showing 1 to 25 of 128. Each trial links to its page on Pharma Observatory.
28 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.